Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company amcure GmbH
DescriptionPeptide that inhibits splice variant v6 of CD44 (CD44v6)
Molecular Target Splice variant v6 of CD44 (CD44v6)
Mechanism of ActionSplice variant v6 of CD44 (CD44v6) inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today